Kubo, T., Hirohashi, Y., Tsukahara, T., Kanaseki, T., Murata, K., Hasegawa, T., & Torigoe, T. (2021). Epithelioid granulomatous lesions express abundant programmed death ligand-1 (PD-L1): A discussion of adverse events in anti-PD-1 antibody-based cancer immunotherapy. Hum Vaccin Immunother.

Kubo, Terufumi, Yoshihiko Hirohashi, Tomohide Tsukahara, Takayuki Kanaseki, Kenji Murata, Tadashi Hasegawa, und Toshihiko Torigoe. "Epithelioid Granulomatous Lesions Express Abundant Programmed Death Ligand-1 (PD-L1): A Discussion of Adverse Events in Anti-PD-1 Antibody-based Cancer Immunotherapy." Hum Vaccin Immunother 2021.

Kubo, Terufumi, et al. "Epithelioid Granulomatous Lesions Express Abundant Programmed Death Ligand-1 (PD-L1): A Discussion of Adverse Events in Anti-PD-1 Antibody-based Cancer Immunotherapy." Hum Vaccin Immunother 2021.